Advertisement

Myxedema coma during long-term amiodarone therapy

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Amiodarone is a potent new antiarrhythmic drug that has multiple effects on thyroid function, including inhibition of extrathyroidal triiodothyronine production and rarely, iodine-induced hypothyroldism. This report describes a man with recurrent ventricular tachycardia in whom hypothyroidism developed during amiodarone therapy and who died of probable myxedema coma. Parenteral and oral thyroxine therapy promptly reduced serum thyroid-stimulating hormone concentrations without increasing the patient's very low serum triiodothyronine concentration. This response to thyroxine suggests that thyroxine itself may have biologic activity and participate directly in regulation of thyrotropln secretion. Because amiodarone-induced hypothyroidism may be life-threatening, thyroid function should be monitored before and during amiodarone therapy, and the drug discontinued or appropriate therapy instituted if hypothyroidism develops.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Marcus FI
        • Fontaine GH
        • Frank R
        • Grosgogeat Y
        Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
        Am Heart J. 1981; 101: 480-493
        • Nademanee K
        • Singh BN
        • Hendrickson JA
        • et al.
        Amiodarone in refractory life-threatening ventricular arrhythmias.
        Ann Intern Med. 1983; 98: 577-584
        • Kaski JC
        • Girotti LA
        • Messuti H
        • Rutitzky B
        • Rosenbaum MB
        Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.
        Circulation. 1981; 64: 273-279
        • Waxman HL
        • Groh WC
        • Marchlinski FE
        • et al.
        Amiodarone for control of sustained ventricular tachyarrhythmia.
        Am J Cardiol. 1982; 50: 1066-1074
        • Melmed S
        • Nademanee K
        • Reed AW
        • et al.
        Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.
        J Clin Endocrinol Metab. 1981; 53: 997-1001
        • Chopra IJ
        A radioimmunoassay for the measurement of thyroxine in plasma.
        J Clin Endocrinol Metab. 1972; 34: 938-947
        • Lieblich J
        • Utiger RO
        Triiodothyronine radioimmunoassay.
        J Clin Invest. 1972; 51: 157-166
        • Utiger RD
        Thyrotropin.
        in: Jaffe B Behrman H Methods of hormone radioimmunoassay. Academic Press, New York1979: 315-325
        • van Rijswijk MH
        • van Heusden WG
        The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.
        Am J Pathol. 1979; 97: 43-58
        • Braverman LE
        • Woeber KA
        • Ingbar SH
        Induction of myxedema by iodide in patients euthyroid after radioiodine or surgical treatment of diffuse toxic goiter.
        N Engl J Med. 1969; 281: 816-821
        • Vagenakis A
        • Braverman LE
        Adverse effects of iodides on thyroid function.
        Med Clin North Am. 1975; 59: 1075
        • Danovitch GM
        • LeRoith D
        • Sikuler SE
        • Straus R
        Amyloid goiter in familial mediterranean fever.
        Clin Endocrinol. 1979; 11: 595-601
        • Glenner GG
        Amyloid deposits and amyloidosis: the B-fibrilloses.
        N Engl J Med. 1980; 302: 1283-1292
        • Glenner GG
        Amyloid deposits and amyloidosis: the B-fibrilloses.
        N Engl J Med. 1980; 302: 1333-1343
        • Daoud FS
        • Nieman RE
        • Vilter RW
        Amyloid goiter in a case of generalized primary amyloidosis.
        Am J Med. 1967; 43: 604-617
        • Burger A
        • Dinichert D
        • Nicod P
        • Jenny M
        • LeMarchand-Beraud T
        • Vallotton MB
        Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine, and thyrotropin.
        J Clin Invest. 1976; 58: 225-229
        • Lambert MJ
        • Burger AG
        • Galeazzi RL
        • Engler O
        Are selective increases in serum thyroxine (T4) due to iodinated inhibitors of T4 monodeiodination indicative of hypothyroidism?.
        J Clin Endocrinol Metab. 1982; 55: 1058-1065
        • Larsen PR
        Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones.
        N Engl J Med. 1982; 306: 23-32
        • Balsam A
        • Ingbar SH
        • Sexton F
        The influence of fasting, diabetes, and several pharmacologic agents in the pathways of thyroxine metabolism in rat liver.
        J Clin Invest. 1978; 62: 415-422
        • Ridgway EC
        • McCammon JA
        • Benotti J
        • Maloof F
        Acute metabolic responses to large intravenous doses of L-thyroxine.
        Ann Intern Med. 1972; 77: 549-555